Results 281 to 290 of about 628,756 (329)
Perfluorohexyloctane Ophthalmic Solution in Patients with Dry Eye Disease Undergoing Cataract Surgery: A Prospective Multicenter Study. [PDF]
Ophthalmol TherHovanesian JA +9 more
europepmc +1 more source
Perfluorohexyloctane eye drops in treating dry eye disease associated with meibomian gland dysfunction: a post hoc analysis by baseline severity. [PDF]
Int OphthalmolLiu Z, Ma L, Li Y, Tian L, Jie Y.
europepmc +1 more source
Efficacy of povidone and propylene glycol-based artificial tears in the treatment of dry eye disease. [PDF]
Arq Bras OftalmolSantos LCD +3 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
JAMA - Journal of the American Medical Association, 2022
Fiona Stapleton, Revathy Mani
exaly +4 more sources
Fiona Stapleton, Revathy Mani
exaly +4 more sources
Acta Biomaterialia, 2023
Dry eye disease (DED) is currently the most prevalent condition seen in ophthalmology outpatient clinics, representing a significant public health issue.
Liling Ou +9 more
semanticscholar +1 more source
Dry eye disease (DED) is currently the most prevalent condition seen in ophthalmology outpatient clinics, representing a significant public health issue.
Liling Ou +9 more
semanticscholar +1 more source
Seminars in Ophthalmology, 2010
Dry eye (DED) is a multifactorial disease that results in symptoms of discomfort, visual disturbance, and tear film instability with potential damage to the ocular surface, accompanied by increased osmolarity of the tear film and inflammation. DED is a common clinical problem and is among the most frequent diagnoses in ophthalmology.
Fabiana de Pinho, Tavares +4 more
openaire +2 more sources
Dry eye (DED) is a multifactorial disease that results in symptoms of discomfort, visual disturbance, and tear film instability with potential damage to the ocular surface, accompanied by increased osmolarity of the tear film and inflammation. DED is a common clinical problem and is among the most frequent diagnoses in ophthalmology.
Fabiana de Pinho, Tavares +4 more
openaire +2 more sources
The Biomedical & Life Sciences Collection, 2018
Dry eye disease is a chronic condition of the corneal surface marked by persistent symptoms of irritation or burning that can cause inflammatory damage to the cornea and conjunctiva if untreated. Common risk factors for this syndrome include advancing age, female sex, low humidity environments, systemic medications, and autoimmune disorders. Treatments
Patricia A, Rouen, Mary L, White
+7 more sources
Dry eye disease is a chronic condition of the corneal surface marked by persistent symptoms of irritation or burning that can cause inflammatory damage to the cornea and conjunctiva if untreated. Common risk factors for this syndrome include advancing age, female sex, low humidity environments, systemic medications, and autoimmune disorders. Treatments
Patricia A, Rouen, Mary L, White
+7 more sources
Dry Eye Disease: An Update in 2022.
JAMA, 2022F. Hakim, Asim V. Farooq
semanticscholar +3 more sources
Ophthalmology (Rochester, Minn.), 2022
OBJECTIVE To evaluate the efficacy and safety of NOV03 (perfluorohexyloctane) ophthalmic drop in patients with dry eye disease (DED) associated with meibomian gland dysfunction (MGD).
J. Tauber +4 more
semanticscholar +1 more source
OBJECTIVE To evaluate the efficacy and safety of NOV03 (perfluorohexyloctane) ophthalmic drop in patients with dry eye disease (DED) associated with meibomian gland dysfunction (MGD).
J. Tauber +4 more
semanticscholar +1 more source